In vitro and in vivo studies have shown that CALB2 promotes hepatocellular carcinoma metastasis via the TRPV2-Ca2+-ERK1/2 signaling pathway (Chu et al., 2022). Here, CALB2 is linked to hepatocellular carcinoma.